PT-30(Shield Therapeutics)

N/A

Report date: 2025/08/15 14:29:30
NME

Base Information

Drug NamePT-30(Shield Therapeutics)
Drug Alias NamePT-30
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIron replacements
TargetsNot applicable
Therapy Area/IndicationsAnemia, Iron-Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPhosphate Therapeutics LtdMedical Research Council
China Registration ClassN/A

Develop Information

Active CompaniesPhosphate Therapeutics LtdMedical Research Council
Inactive CompaniesN/A
Active IndicationsAnemia, Iron-Deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A